Toth Financial Advisory’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.3K Buy
217
+100
+85% +$14K ﹤0.01% 436
2026
Q2
$14.8K Sell
117
-11
-9% -$1.45K ﹤0.01% 542
2026
Q1
$17.8K Buy
128
+67
+110% +$9.38K ﹤0.01% 499
2025
Q4
$7.49K Buy
61
+8
+15% +$972 ﹤0.01% 594
2025
Q3
$5.88K Buy
53
+1
+2% +$114 ﹤0.01% 592
2025
Q2
$5.77K Hold
52
– – ﹤0.01% 545
2025
Q1
$5.83K Hold
52
– – ﹤0.01% 512
2024
Q4
$4.8K Hold
52
– – ﹤0.01% 514
2024
Q3
$4.36K Hold
52
– – ﹤0.01% 534
2024
Q2
$3.57K Hold
52
– – ﹤0.01% 549
2024
Q1
$3.81K Sell
52
-100
-66% -$7.69K ﹤0.01% 551
2023
Q4
$12.3K Buy
152
+100
+192% +$7.78K ﹤0.01% 434
2023
Q3
$3.9K Sell
52
-50
-49% -$3.85K ﹤0.01% 565
2023
Q2
$7.86K Sell
102
-1
-1% -$80 ﹤0.01% 502
2023
Q1
$8.55K Buy
103
+51
+98% +$4.22K ﹤0.01% 481
2022
Q4
$4.46K Buy
52
+17
+49% +$1.35K ﹤0.01% 514
2022
Q3
$2K Buy
+35
New +$2.21K ﹤0.01% 636
2021
Q4
– Sell
-120
Closed -$8K – 784
2021
Q3
$8K Hold
120
– – ﹤0.01% 509
2021
Q2
$8K Hold
120
– – ﹤0.01% 475
2021
Q1
$8K Hold
120
– – ﹤0.01% 483
2020
Q4
$7K Sell
120
-200
-63% -$12.1K ﹤0.01% 436
2020
Q3
$20K Sell
320
-195
-38% -$13.5K ﹤0.01% 316
2020
Q2
$40K Buy
515
+395
+329% +$30.3K 0.01% 237
2020
Q1
$9K Buy
+120
New +$8.29K ﹤0.01% 285
2018
Q2
– Sell
-137
Closed -$10K – 435
2018
Q1
$10K Hold
137
– – ﹤0.01% 317
2017
Q4
$10K Buy
+137
New +$10.4K ﹤0.01% 320

Other funds holding GILD

Toth Financial Advisory's GILD Position: Q3 2026 in Review

Toth Financial Advisory increased its Gilead Sciences (GILD) stake by 85% in Q3 2026, buying an estimated $14K and bringing the position to 217 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #436.

Toth Financial Advisory first reported a position in GILD in Q4 2017 and has held it in 26 quarters since. The position peaked at $40K in Q2 2020. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Toth Financial Advisory held 217 shares of Gilead Sciences worth $32.3K as of Q3 2026.
  • Toth Financial Advisory bought 100 Gilead Sciences shares in Q3 2026, an estimated $14K.
  • Gilead Sciences made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #436 holding.
  • Toth Financial Advisory first reported a position in Gilead Sciences in Q4 2017 and has held it in 26 quarters since.
  • Toth Financial Advisory's Gilead Sciences position peaked at $40K in Q2 2020.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.